153 related articles for article (PubMed ID: 16636661)
1. Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7.
Ohlenschläger O; Seiboth T; Zengerling H; Briese L; Marchanka A; Ramachandran R; Baum M; Korbas M; Meyer-Klaucke W; Dürst M; Görlach M
Oncogene; 2006 Sep; 25(44):5953-9. PubMed ID: 16636661
[TBL] [Abstract][Full Text] [Related]
2. A C-terminal hydrophobic, solvent-protected core and a flexible N-terminus are potentially required for human papillomavirus 18 E7 protein functionality.
Liu S; Tian Y; Greenaway FT; Sun MZ
Biochimie; 2010 Jul; 92(7):901-8. PubMed ID: 20211680
[TBL] [Abstract][Full Text] [Related]
3. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein.
Brokaw JL; Yee CL; Münger K
Virology; 1994 Dec; 205(2):603-7. PubMed ID: 7975265
[TBL] [Abstract][Full Text] [Related]
4. Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs.
Uversky VN; Roman A; Oldfield CJ; Dunker AK
J Proteome Res; 2006 Aug; 5(8):1829-42. PubMed ID: 16889404
[TBL] [Abstract][Full Text] [Related]
5. Folding of a dimeric beta-barrel: residual structure in the urea denatured state of the human papillomavirus E2 DNA binding domain.
Mok YK; Alonso LG; Lima LM; Bycroft M; de Prat-Gay G
Protein Sci; 2000 Apr; 9(4):799-811. PubMed ID: 10794423
[TBL] [Abstract][Full Text] [Related]
6. Domain substructure of HPV E6 oncoprotein: biophysical characterization of the E6 C-terminal DNA-binding domain.
Nominé Y; Charbonnier S; Ristriani T; Stier G; Masson M; Cavusoglu N; Van Dorsselaer A; Weiss E; Kieffer B; Travé G
Biochemistry; 2003 May; 42(17):4909-17. PubMed ID: 12718532
[TBL] [Abstract][Full Text] [Related]
7. The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells.
Braspenning J; Marchini A; Albarani V; Levy L; Ciccolini F; Cremonesi C; Ralston R; Gissmann L; Tommasino M
Oncogene; 1998 Feb; 16(8):1085-9. PubMed ID: 9519882
[TBL] [Abstract][Full Text] [Related]
8. Predicted alpha-helix/beta-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7.
Ullman CG; Haris PI; Galloway DA; Emery VC; Perkins SJ
Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):229-39. PubMed ID: 8870673
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus type 77 E7 protein is a weak deregulator of cell cycle.
Mansour M; Touka M; Malena A; Indiveri C; Dong W; Gionfriddo I; Accardi R; Paradiso A; Sylla BS; Gabet AS; Tommasino M
Cancer Lett; 2007 Feb; 246(1-2):274-81. PubMed ID: 16650526
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous human papilloma virus type 16 E7 and cdk inhibitor p21 expression induces apoptosis and cathepsin B activation.
Kaznelson DW; Bruun S; Monrad A; Gjerløv S; Birk J; Röpke C; Norrild B
Virology; 2004 Mar; 320(2):301-12. PubMed ID: 15016552
[TBL] [Abstract][Full Text] [Related]
11. The HPV16 E7 viral oncoprotein self-assembles into defined spherical oligomers.
Alonso LG; García-Alai MM; Smal C; Centeno JM; Iacono R; Castaño E; Gualfetti P; de Prat-Gay G
Biochemistry; 2004 Mar; 43(12):3310-7. PubMed ID: 15035602
[TBL] [Abstract][Full Text] [Related]
12. Chaperone holdase activity of human papillomavirus E7 oncoprotein.
Alonso LG; Smal C; Garcia-Alai MM; Chemes L; Salame M; de Prat-Gay G
Biochemistry; 2006 Jan; 45(3):657-67. PubMed ID: 16411741
[TBL] [Abstract][Full Text] [Related]
13. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7.
Lee JO; Russo AA; Pavletich NP
Nature; 1998 Feb; 391(6670):859-65. PubMed ID: 9495340
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
15. Identification of domains required for transcriptional activation and protein dimerization in the human papillomavirus type-16 E7 protein.
Zwerschke W; Joswig S; Jansen-Dürr P
Oncogene; 1996 Jan; 12(1):213-20. PubMed ID: 8552395
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis.
Nominé Y; Masson M; Charbonnier S; Zanier K; Ristriani T; Deryckère F; Sibler AP; Desplancq D; Atkinson RA; Weiss E; Orfanoudakis G; Kieffer B; Travé G
Mol Cell; 2006 Mar; 21(5):665-78. PubMed ID: 16507364
[TBL] [Abstract][Full Text] [Related]
17. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
[TBL] [Abstract][Full Text] [Related]
18. One-step purification of recombinant human papillomavirus type 16 E7 oncoprotein and its binding to the retinoblastoma gene product.
Kasher MS; Wakulchik M; Cook JA; Smith MC
Biotechniques; 1993 Apr; 14(4):630-41. PubMed ID: 8386522
[TBL] [Abstract][Full Text] [Related]
19. High-risk (HPV16) human papillomavirus E7 oncoprotein is highly stable and extended, with conformational transitions that could explain its multiple cellular binding partners.
Alonso LG; García-Alai MM; Nadra AD; Lapeña AN; Almeida FL; Gualfetti P; Prat-Gay GD
Biochemistry; 2002 Aug; 41(33):10510-8. PubMed ID: 12173938
[TBL] [Abstract][Full Text] [Related]
20. The N-terminal module of HPV16 E7 is an intrinsically disordered domain that confers conformational and recognition plasticity to the oncoprotein.
García-Alai MM; Alonso LG; de Prat-Gay G
Biochemistry; 2007 Sep; 46(37):10405-12. PubMed ID: 17715947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
